Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products

28.32B 28.54B 34.12B 45.04B 65.18B

Total Assets

48.81B 49.49B 64.01B 78.71B 112B

Interest Expense

-340M -332M -486M -781M -

Income Tax Expense

574M 562M 1.31B 2.09B 5.09B

CAPEX

-1.87B -2.48B -3.45B -5.06B -7.84B

EBT

6.16B 6.81B 6.55B 12.68B 25.73B

D&A

1.55B 1.52B 1.53B 1.77B 2B

Net Income

5.58B 6.24B 5.24B 10.59B 20.64B

EBT

- - - - -

EBT

- - - - -

EBT

- - - - -

EBT

- - - - -

EBT

- - - - -

EBT

- - - - -

Veterinary Drugs

          

Animal Health Products

- - - - -

EBT

- - - - -

D&A

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States (U.S.)

16.81B 18.19B 21.79B 30.38B 43.48B

Total Assets

- - - - -

Europe

4.78B 4.3B 6.17B 6.92B 11.56B

Total Assets

- - - - -

Rest of world

2.7B 2.85B 2.95B 4.27B 6.06B

Total Assets

1.69B 1.63B 1.78B 2.16B 3.52B

Japan

2.37B 1.75B 1.67B 1.81B 2.13B

Total Assets

- - - - -

Total Assets

6.62B 7.71B 9.99B 13.4B 18.76B

Total Assets

1.7B 1.9B 2.72B 3.2B 4.32B

China

1.66B 1.45B 1.54B 1.66B 1.95B